ramelteon has been researched along with Neurodegenerative Diseases in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Gu, C; Liu, CF; Liu, JY; Sun, HY; Wang, F; Wang, GH; Wei, SZ; Zhang, YT | 1 |
| Cai, M; Gu, X; Han, F; Han, L; Liu, D; Liu, W; Ma, Q | 1 |
| Frydman-Marom, A; Laudon, M | 1 |
1 review(s) available for ramelteon and Neurodegenerative Diseases
| Article | Year |
|---|---|
Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders.
Topics: Acetamides; Animals; Benzofurans; Clinical Trials as Topic; Cyclopropanes; Humans; Hypnotics and Sedatives; Indenes; Melatonin; Neurodegenerative Diseases; Receptors, Melatonin; Sleep Wake Disorders | 2014 |
2 other study(ies) available for ramelteon and Neurodegenerative Diseases
| Article | Year |
|---|---|
Microglial MT1 activation inhibits LPS-induced neuroinflammation via regulation of metabolic reprogramming.
Topics: Animals; Disease Models, Animal; Indenes; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Microglia; Neurodegenerative Diseases; Parkinson Disease; Receptor, Melatonin, MT1 | 2021 |
The protective effects of Ramelteon against 6-OHDA-induced cellular senescence in human SH-SY5Y neuronal cells.
Topics: Aged; Cell Line, Tumor; Cellular Senescence; Humans; Indenes; Neurodegenerative Diseases; Oxidopamine | 2021 |